Skip to main content
. Author manuscript; available in PMC: 2007 Oct 10.
Published in final edited form as: Nurs Res. 2006;55(3):161–171. doi: 10.1097/00006199-200605000-00002

TABLE 4.

HLM Final Estimation of Fixed Effects: Testing Moderators of Physical Functioning

Expected status at Week 20, π0j Coefficient SE p
β00 Intercept 55.460 5.519 .000***
β01 Intervention 7.686 8.018 .339
β02 Age −0.325 0.268 .227
β03 Intervention × Age −0.086 0.394 .827
β04 Chronic health condition −15.428 6.227 .014**
β05 Intervention × Chronic Health condition 15.287 8.370 .069*
β06 Depression −1.300 0.358 .001***
β07 Intervention × Depression 1.052 0.511 .041**
β08 Symptom limitations 0.107 0.200 .595
β09 Intervention × Symptom limitations −0.667 0.261 .012**
β010 Male lung cancer 15.708 6.790 .022**
β011 Intervention × Male lung cancer −17.523 9.347 .062*
β012 Female breast cancer 18.069 5.461 .001*
β013 Intervention × Female Breast cancer −4.126 7.663 .590
β014 Female other cancer 8.106 6.355 .204
β015 Intervention × Female other cancer 3.729 8.888 .675
β016 Male other cancer 12.787 9.104 .162
β017 Intervention × Male other cancer 6.964 11.923 .559
Linear-expected change at Week 20, π1j Coefficient SE p
β10 Time 2.348 1.017 .022**
β11 Time × Intervention −1.025 1.528 .503
β12 Time × Age −0.032 0.075 .668
β13 Time × Intervention × Age −0.079 0.112 .478
β14 Time × Chronic health Condition −2.095 1.827 .254
β15 Time × Intervention × Chronic health condition 5.757 2.477 .021**
β16 Time × Depression −0.175 0.110 .114
β17 Time × Intervention × Depression 0.261 0.155 .094*
β18 Time × Symptom limitation 0.070 0.059 .241
β19 Time × Intervention × Symptom limitation −0.179 0.079 .024**
Quadratic-expected acceleration or change in slope at Week 20, π2j Coefficient SE p
β20 Time2 −0.433 0.291 .139
β21 Time2 × Intervention −0.142 0.442 .749
β22 Time2 × Age −0.026 0.022 .233
β23 Time2 × Intervention × Age 0.022 0.032 .492
β24 Time2 × Chronic health Condition 1.085 0.529 .041**
β25 Time2 × Intervention × chronic health condition −1.187 0.718 .100
β26 Time2 × Depression 0.076 0.031 .015**
β27 Time2 × Intervention × Depression −0.125 0.045 .006***
β28 Time2 × Symptom limitation −0.034 0.017 .045**
β29 Time2 × Intervention × Symptom limitation 0.063 0.023 .008***
Cubic-expected change in acceleration over all time points, π3j Coefficient SE p
β30 Time3 −0.153 0.076 .044**
β31 Time3 × Intervention 0.021 0.114 .854
β32 Time3 × Age −0.002 0.006 .613
β33 Time3 × Intervention × Age 0.007 0.008 .407
β34 Time3 × Chronic health Condition 0.236 0.136 .083*
β35 Time3 × Intervention × Chronic health condition −0.393 0.185 .034**
β36 Time3 × Depression 0.016 0.008 .044**
β37 Time3 × Intervention × Depression −0.031 0.012 .009***
β38 Time3 × Symptom limitation −0.003 0.004 .438
β39 Time3 × Intervention × Symptom limitation 0.015 0.006 .011**

Note: β00 intercept = expected physical functioning status at Week 20 for a female with lung cancer in the nonintervention group, with age = 60, low chronic conditions, depressive symptomatology = 16, and symptom limitations = 22.

Note: β10 Time is the expected change in physical functioning at Week 20 for an individual with cancer in the nonintervention group, with age = 60, low chronic conditions, depressive symptomatology = 16, and symptom limitations = 22.

Note: β20 Time2 is the expected deceleration in physical functioning at Week 20 for an individual with cancer in the nonintervention group, with age = 60, low chronic conditions, depressive symptomatology = 16, and symptom limitations = 22.

Note: β30 Time3 is the expected change in deceleration of physical functioning for an individual with cancer in the nonintervention group, with age = 60, low chronic conditions, depressive symptomatology = 16, and symptom limitations = 22.

*

Note: p < .1;

**

p < .05;

***

p < .01.